Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson Passes This Key Test
Motley Fool
Sat, 03/17/12 - 10:50 am
Tags:
JNJ
J&J CEO Weldon retirement pay seen at $143.5 mln
Reuters
Thu, 03/15/12 - 09:07 am
Tags:
JNJ, William Weldon, executive pay
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Tags:
Seattle Genetics, Celldex, Arqule, Daiichi Sankyo, JNJ, Medivation, Dendreon, Aveo Pharmaceutical, Ariad Pharmaceuticals, AstraZeneca, Array Biopharma, Oncothyreon
A Drug Class Back From the Dead?
Motley Fool
Wed, 03/14/12 - 09:42 am
Tags:
Pfizer, Regeneron, JNJ, Sanofi, AstraZeneca, FDA, NGF blockers
Don't Expect Too Much From New Pain Drugs, Analyst Says
Forbes
Tue, 03/13/12 - 11:07 am
Tags:
painkillers, NGF blockers, Amgen, Regeneron, JNJ
Vical's Allovectin: Why Hasn't The Trial Been Stopped?
Seeking Alpha
Mon, 03/12/12 - 08:44 pm
Tags:
Vical, Allovectin, metastatic melanoma, melanoma, Zytiga, JNJ
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk
Yahoo/AP
Mon, 03/12/12 - 05:47 pm
Tags:
FDA, painkillers, Pfizer, JNJ, Regeneron, arthritis
J&J Said to Face Demand to Raise Risperdal Accord Offer by $800 Million
Bloomberg
Mon, 03/12/12 - 05:45 pm
Tags:
JNJ, Risperdal
Johnson & Johnson: A Solid Buy Candidate For 2012
Seeking Alpha
Mon, 03/12/12 - 05:30 pm
Tags:
JNJ
Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
Seeking Alpha
Sun, 03/11/12 - 12:12 pm
Tags:
Zytiga, Provenge, prostate cancer, JNJ, Dendreon
U.S. nixes tentative $1 bln settlement with J&J -WSJ
Reuters
Sat, 03/10/12 - 04:08 pm
Tags:
JNJ, legal, Risperdal
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
Tags:
JNJ, prostate cancer, Dendreon, Provenge, Medivation, Zytiga, MDV3100
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thu, 03/8/12 - 09:55 am
Tags:
Pfizer, JNJ, FDA, joint failure, painkillers, fulranumab, Sanofi, Regeneron, tanezumab, REGN475/SAR164877
US warns Synthes on violations; threatens fine
Reuters
Tue, 03/6/12 - 11:23 am
Tags:
Synthes, JNJ, warnings
Most Popular Drug Manufacturers among Hedge Funds
Motley Fool
Mon, 03/5/12 - 06:15 pm
Tags:
Pfizer, hedge funds, Sanofi, JNJ, Merck, Abbott Laboratories, Eli Lilly, Bristol-Myers Squibb
Johnson & Johnson Could Double In 5 Years
Seeking Alpha
Sun, 03/4/12 - 12:19 pm
Tags:
JNJ
Healthy Johnson & Johnson Stock Going To $72
Forbes
Sat, 03/3/12 - 12:23 pm
Tags:
JNJ
Pharmacyclics Gains Ahead of Investor Call
Bloomberg
Thu, 03/1/12 - 05:59 pm
Tags:
Pharmacyclics, JNJ
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville
Wed, 02/29/12 - 04:52 pm
Tags:
Merck, Pfizer, Bristol-Myers Squibb, Chelsea Therapeutics, Affymax, Astex, JNJ, Discovery Labs, Ariad Pharmaceuticals, NeurogesX, Amgen
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Bloomberg
Wed, 02/29/12 - 10:12 am
Tags:
obesity, M&A, Vivus, Qnexa, JNJ, Merck, Bristol-Myers Squibb, Arena Pharmaceuticals, Orexigen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.